Cue Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. 

CEO
Daniel R. Passeri
CEODaniel R. Passeri
Employees
41
Employees41
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
41
Employees41

CUE Key Statistics

Market cap
55.62M
Market cap55.62M
Price-Earnings ratio
-1.15
Price-Earnings ratio-1.15
Dividend yield
Dividend yield
Average volume
236.90K
Average volume236.90K
High today
$0.7996
High today$0.7996
Low today
$0.705
Low today$0.705
Open price
$0.78
Open price$0.78
Volume
220.95K
Volume220.95K
52 Week high
$1.99
52 Week high$1.99
52 Week low
$0.45
52 Week low$0.45

People also own

Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.